Inpatient glycemic control and community-acquired pneumonia outcomes in the pre-COVID-19 era: reviewing the evidence to pave the road for future studies

BMJ Open Diabetes Res Care. 2022 Jul;10(4):e003011. doi: 10.1136/bmjdrc-2022-003011.

Authors

Paras B Mehta¹, Aidar R Gosmanov^{2

3}

Affiliations

¹ Division of Endocrinology and Metabolism, University of California San Francisco, San Francisco, California, USA paras.mehta@ucsf.edu.
² Division of Endocrinology, Department of Medicine, Albany Medical College, Albany, New York, USA.
³ Endocrinology Section, Stratton VAMC, Albany, New York, USA.

No abstract available

Keywords: COVID-19; Diabetes Complications; Diabetes Mellitus, Type 2; Hyperglycemia.

Publication types

Editorial
Comment

MeSH terms

COVID-19*
Community-Acquired Infections* / epidemiology
Community-Acquired Infections* / prevention & control
Glycemic Control
Humans
Inpatients
Pneumonia*